Literature DB >> 9679831

Coexistence of Kaposi's sarcoma and tuberculosis in a renal transplant recipient.

A Y Wang1, P K Li, K F To, F M Lai, K N Lai.   

Abstract

BACKGROUND: We describe a case of Kaposi's sarcoma that developed in a renal transplant recipient as early as 5 months after the transplant.
METHOD: The Kaposi's sarcoma evolved in an aggressive manner, involving the oral mucosa, the cervical and mediastinal lymph nodes, the gastrointestinal tract, and possibly the lung. Histological features of tuberculosis were also detected incidentally on an excisional biopsy of the lymph node. The patient was given 12 months of antituberculous chemotherapy. At the same time, immunosuppression was gradually tapered over a 2- to 3-week period.
RESULTS: Despite the aggressive nature of the disease, the Kaposi's sarcoma regressed completely without the institution of chemotherapy. The patient remained disease-free after a follow-up period of 30 months. The kidney allograft, however, was rejected and the patient required dialysis again.
CONCLUSION: Although lymphadenopathy is a well-recognized feature in organ transplant recipients who develop Kaposi's sarcoma, one has to watch out for other coexisting diseases, such as tuberculosis, lymphoma, and cytomegalovirus infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679831     DOI: 10.1097/00007890-199807150-00018

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  [Thrust of Kaposi sarcoma and elevated CA 19-9: think tubersulosis!].

Authors:  Faida Ajili; Héla Hariz; Asmahen Souissi; Rim Abid; Najeh Boussetta; Besma Laabidi; Riadh Battikh; Bassem Louzir; Salah Othmani
Journal:  Pan Afr Med J       Date:  2013-11-05

2.  Simultaneous Association of Pulmonary Tuberculosis and Kaposi's Sarcoma in an Immunocompetent Subject: A Case Report and Literature Review.

Authors:  Sofia Baina; Jihane Achrane; Jouda Benamor; Jamal Eddine Bourkadi
Journal:  Case Rep Pulmonol       Date:  2019-10-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.